Difficulties in Differential Diagnosis of Post-Vaccination Period. Practical Examples
https://doi.org/10.31631/2073-3046-2017-16-6-66-70
Abstract
About the Authors
E. P. NacharovaRussian Federation
S. M. Kharit
Russian Federation
References
1. Pokrovskij V. I., Semenov B. F. Vaccineprophylaxis. The results of the 20th century and the prospects for the next century. Zhurnal mikrobiologii, epidemiilogii i immunologii. [Journal of Microbiology Epidemiology and Immunobiology]. 1999; 5: 6–8 (in Russian).
2. Onishchenko G. G. Immunoprophylaxis as an instrument for maintaining public health and increasing longevity. Epidemiologiya i infektsionnye bolezni. [Epidimiology and infectious diseases]. 2004; 6: 4–7 (in Russian).
3. Semyonov B. F., Lyabis O. I., Mihajlova N. A. The main stages of development of vaccinology and vaccine prevention. In: Vakciny i vakcinaciya: na-cional’noe rukovodstvo. Ed.: V. V. Zverev, B. F. Semyonov, R. M. Haitov. Moscow: GEHOTAR-Media. 2011: 18–25 (in Russian).
4. Bobat S., Cunningham A. F. Bacterial infections and vaccines. Adv. Exp. Med. Biol. 2014; 828: 75–98.
5. Lakotkina E. A., Harit S. M., CHernyaeva T. V., Brusov N. K. Post-vaccination complications (clinic, diagnosis, treatment, prophylaxis). Ed.: V. V. Ivanova. Posobie dlya prakticheskogo vracha. St. Peterburg med. inform.-analit. centr. St. Petersburg. 2004: 79 (in Russian).
6. Yasinskij A. A., Miheeva I. V. Safety of immunization. In: Vakciny i vakcinaciya: nacional’noe rukovodstvo. Ed.: V. V. Zverev, B. F. Semyonov, R. M. Haitov. Moscow: GEHOTAR-Media. 2011: 137–162 (in Russian).
7. Harit S. M., CHernyaeva T. V,, Lakotkina E. A. Structure of postvaccination period diseases (analysis of observations for 40 years). Epidemilogia i Vaccinoprofilactica [Epidemiology and Vaccine Prevention]. 2010; 2 (51): 64–69 (in Russian).
8. Boyman O., Comte D., Spertini F. Adverse reactions to biologic agents and their medical management. Nat. Rev. Rheumatol. 2014; 10 (10): 612–27.
9. Soriano A., Nesher G., Shoenfeld Y. Predicting post-vaccination autoimmunity: who might be at risk? Pharmacol. Res. 2015; 92: 18–22.
10. Global Advisory Committee on Vaccine Safety (GACVS); WHO secretariat. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert. Rev. Vaccines. 2009; 8 (6): 705–716.
11. Jones P.G., Cowan G., Gravendyck M. et al. Regulatory requirements for vaccine authorisation. Rev Sci Tech. 2007; 26 (2): 379–393.
12. Le Louët H., Loupi E., Haramburu F. Which pharmacovigilance for vaccines? Therapie. 2007; 62 (3): 241–247.
13. Decree of the Government of the Russian Federation No. 885 of August 2, 1999. Available at: http://www.rosminzdrav.ru/documents/8002-postanovlenie-pravitelstva-rf-885-ot-2-avgusta-1999-g.
14. Advers events associated with childhood vaccine. Institute of medicine/ National Academy. Press.Washington. DC; 1994: 465.
Review
For citations:
Nacharova E.P., Kharit S.M. Difficulties in Differential Diagnosis of Post-Vaccination Period. Practical Examples. Epidemiology and Vaccinal Prevention. 2017;16(6):66-70. (In Russ.) https://doi.org/10.31631/2073-3046-2017-16-6-66-70